Regulation & law · 30/09/2025Updated: 10/17/2026 · 1 min read
U.S. Federal Trade Commission Approves Pfizer's Acquisition of BioNTech, Following Review of Proposed Transaction
Summary
The U.S. Federal Trade Commission has approved Pfizer's acquisition of BioNTech, following a review of the proposed transaction, which is expected to close in the first half of 2024, subject to customary closing conditions
Original source language: Federal Register — Justice DepartmentOpen original release →